Odonate Therapeutics, Inc. Shareholders' Equity
Odonate Therapeutics, Inc. had Shareholders' Equity of $71.37 million as of 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2021-11-10
- 2021-09-30: Stockholders' Equity Attributable to Parent $71.37M.
- 2021-06-30: Stockholders' Equity Attributable to Parent $84.63M.
- 2021-03-31: Stockholders' Equity Attributable to Parent $105.30M.
- 2020-12-31: Stockholders' Equity Attributable to Parent $136.15M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2021-09-30 | $71.37M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $84.63M 10-Q · filed 2021-11-10 |
| 2021-03-31 | $105.30M 10-Q · filed 2021-11-10 |
| 2020-12-31 | $136.15M 10-Q · filed 2021-11-10 |
| 2020-09-30 | $165.60M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $105.55M 10-Q · filed 2021-11-10 |
| 2020-03-31 | $135.24M 10-Q · filed 2021-11-10 |
| 2019-12-31 | $162.30M 10-Q · filed 2021-11-10 |
| 2019-09-30 | $186.20M 10-Q · filed 2020-10-28 |
| 2019-06-30 | $190.86M 10-Q · filed 2020-10-28 |
| 2019-03-31 | $98.44M 10-Q · filed 2020-10-28 |
| 2018-12-31 | $124.00M 10-K · filed 2021-02-23 |
| 2018-09-30 | $150.68M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $172.32M 10-Q · filed 2019-11-06 |
| 2018-03-31 | $190.02M 10-Q · filed 2019-11-06 |
| 2017-12-31 | $195.98M 10-K · filed 2020-02-20 |
| 2016-12-31 | $2.28M 10-K · filed 2019-02-22 |